nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—ADRB1—dilated cardiomyopathy	0.408	0.543	CbGaD
Atenolol—ADRB2—dilated cardiomyopathy	0.343	0.457	CbGaD
Atenolol—ABCB1—Lisinopril—dilated cardiomyopathy	0.0808	0.532	CbGbCtD
Atenolol—ABCB1—Spironolactone—dilated cardiomyopathy	0.0711	0.468	CbGbCtD
Atenolol—Cholestasis intrahepatic—Furosemide—dilated cardiomyopathy	0.0108	0.121	CcSEcCtD
Atenolol—Infarction—Lisinopril—dilated cardiomyopathy	0.00306	0.0343	CcSEcCtD
Atenolol—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.00271	0.0304	CcSEcCtD
Atenolol—Atrial flutter—Lisinopril—dilated cardiomyopathy	0.00223	0.025	CcSEcCtD
Atenolol—Leg pain—Lisinopril—dilated cardiomyopathy	0.00184	0.0206	CcSEcCtD
Atenolol—Lethargy—Spironolactone—dilated cardiomyopathy	0.00154	0.0173	CcSEcCtD
Atenolol—Cholestasis—Furosemide—dilated cardiomyopathy	0.00149	0.0167	CcSEcCtD
Atenolol—Ataxia—Spironolactone—dilated cardiomyopathy	0.00142	0.0159	CcSEcCtD
Atenolol—Psoriasis—Lisinopril—dilated cardiomyopathy	0.00135	0.0151	CcSEcCtD
Atenolol—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0012	0.0135	CcSEcCtD
Atenolol—Throat sore—Lisinopril—dilated cardiomyopathy	0.00118	0.0132	CcSEcCtD
Atenolol—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00117	0.0131	CcSEcCtD
Atenolol—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00116	0.013	CcSEcCtD
Atenolol—Renal failure—Spironolactone—dilated cardiomyopathy	0.00114	0.0128	CcSEcCtD
Atenolol—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00109	0.0122	CcSEcCtD
Atenolol—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00101	0.0113	CcSEcCtD
Atenolol—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.000933	0.0105	CcSEcCtD
Atenolol—Alopecia—Spironolactone—dilated cardiomyopathy	0.000922	0.0103	CcSEcCtD
Atenolol—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000918	0.0103	CcSEcCtD
Atenolol—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00087	0.00975	CcSEcCtD
Atenolol—Purpura—Furosemide—dilated cardiomyopathy	0.000852	0.00955	CcSEcCtD
Atenolol—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000849	0.00951	CcSEcCtD
Atenolol—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000843	0.00945	CcSEcCtD
Atenolol—Lethargy—Furosemide—dilated cardiomyopathy	0.000838	0.00939	CcSEcCtD
Atenolol—Wheezing—Lisinopril—dilated cardiomyopathy	0.000824	0.00924	CcSEcCtD
Atenolol—Malaise—Spironolactone—dilated cardiomyopathy	0.000819	0.00919	CcSEcCtD
Atenolol—Discomfort—Spironolactone—dilated cardiomyopathy	0.000764	0.00857	CcSEcCtD
Atenolol—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000759	0.00851	CcSEcCtD
Atenolol—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000755	0.00847	CcSEcCtD
Atenolol—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00075	0.00841	CcSEcCtD
Atenolol—Confusional state—Spironolactone—dilated cardiomyopathy	0.000748	0.00838	CcSEcCtD
Atenolol—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000726	0.00814	CcSEcCtD
Atenolol—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.000676	0.00758	CcSEcCtD
Atenolol—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000664	0.00745	CcSEcCtD
Atenolol—Somnolence—Spironolactone—dilated cardiomyopathy	0.000659	0.00739	CcSEcCtD
Atenolol—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00065	0.00729	CcSEcCtD
Atenolol—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00064	0.00718	CcSEcCtD
Atenolol—Drowsiness—Furosemide—dilated cardiomyopathy	0.000633	0.00709	CcSEcCtD
Atenolol—Renal failure—Furosemide—dilated cardiomyopathy	0.000622	0.00697	CcSEcCtD
Atenolol—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000616	0.00691	CcSEcCtD
Atenolol—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000611	0.00685	CcSEcCtD
Atenolol—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000611	0.00685	CcSEcCtD
Atenolol—Sweating—Furosemide—dilated cardiomyopathy	0.000607	0.0068	CcSEcCtD
Atenolol—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00059	0.00662	CcSEcCtD
Atenolol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000586	0.00657	CcSEcCtD
Atenolol—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000586	0.00657	CcSEcCtD
Atenolol—Practolol—ADRB1—dilated cardiomyopathy	0.000582	0.0767	CrCbGaD
Atenolol—Ataxia—Lisinopril—dilated cardiomyopathy	0.000579	0.00649	CcSEcCtD
Atenolol—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000563	0.00631	CcSEcCtD
Atenolol—Visual impairment—Furosemide—dilated cardiomyopathy	0.000547	0.00614	CcSEcCtD
Atenolol—Tinnitus—Furosemide—dilated cardiomyopathy	0.00053	0.00594	CcSEcCtD
Atenolol—Metipranolol—ADRB1—dilated cardiomyopathy	0.000527	0.0694	CrCbGaD
Atenolol—Pruritus—Spironolactone—dilated cardiomyopathy	0.000525	0.00588	CcSEcCtD
Atenolol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000524	0.00587	CcSEcCtD
Atenolol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000507	0.00569	CcSEcCtD
Atenolol—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000507	0.00569	CcSEcCtD
Atenolol—Dizziness—Spironolactone—dilated cardiomyopathy	0.00049	0.0055	CcSEcCtD
Atenolol—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00049	0.0055	CcSEcCtD
Atenolol—Depression—Lisinopril—dilated cardiomyopathy	0.000473	0.00531	CcSEcCtD
Atenolol—Sotalol—ADRB1—dilated cardiomyopathy	0.000469	0.0618	CrCbGaD
Atenolol—Rash—Spironolactone—dilated cardiomyopathy	0.000468	0.00524	CcSEcCtD
Atenolol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000467	0.00524	CcSEcCtD
Atenolol—Renal failure—Lisinopril—dilated cardiomyopathy	0.000467	0.00523	CcSEcCtD
Atenolol—Vision blurred—Furosemide—dilated cardiomyopathy	0.000466	0.00522	CcSEcCtD
Atenolol—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000465	0.00522	CcSEcCtD
Atenolol—Headache—Spironolactone—dilated cardiomyopathy	0.000465	0.00521	CcSEcCtD
Atenolol—Sweating—Lisinopril—dilated cardiomyopathy	0.000455	0.0051	CcSEcCtD
Atenolol—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000448	0.00502	CcSEcCtD
Atenolol—Vertigo—Furosemide—dilated cardiomyopathy	0.000444	0.00498	CcSEcCtD
Atenolol—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000443	0.00497	CcSEcCtD
Atenolol—Metipranolol—ADRB2—dilated cardiomyopathy	0.000443	0.0584	CrCbGaD
Atenolol—Nausea—Spironolactone—dilated cardiomyopathy	0.000441	0.00494	CcSEcCtD
Atenolol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000434	0.00486	CcSEcCtD
Atenolol—Hallucination—Lisinopril—dilated cardiomyopathy	0.000424	0.00475	CcSEcCtD
Atenolol—Esmolol—ADRB1—dilated cardiomyopathy	0.000418	0.0551	CrCbGaD
Atenolol—Dry mouth—Furosemide—dilated cardiomyopathy	0.000412	0.00461	CcSEcCtD
Atenolol—Confusional state—Furosemide—dilated cardiomyopathy	0.000407	0.00456	CcSEcCtD
Atenolol—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000397	0.00445	CcSEcCtD
Atenolol—Shock—Furosemide—dilated cardiomyopathy	0.000397	0.00445	CcSEcCtD
Atenolol—Flushing—Lisinopril—dilated cardiomyopathy	0.000395	0.00443	CcSEcCtD
Atenolol—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000395	0.00443	CcSEcCtD
Atenolol—Sotalol—ADRB2—dilated cardiomyopathy	0.000395	0.052	CrCbGaD
Atenolol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00039	0.00437	CcSEcCtD
Atenolol—Anorexia—Furosemide—dilated cardiomyopathy	0.000385	0.00431	CcSEcCtD
Atenolol—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000381	0.00427	CcSEcCtD
Atenolol—Hypotension—Furosemide—dilated cardiomyopathy	0.000377	0.00423	CcSEcCtD
Atenolol—Alopecia—Lisinopril—dilated cardiomyopathy	0.000377	0.00422	CcSEcCtD
Atenolol—Betaxolol—ADRB1—dilated cardiomyopathy	0.000368	0.0485	CrCbGaD
Atenolol—Tension—Lisinopril—dilated cardiomyopathy	0.000364	0.00408	CcSEcCtD
Atenolol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000362	0.00406	CcSEcCtD
Atenolol—Nervousness—Lisinopril—dilated cardiomyopathy	0.00036	0.00404	CcSEcCtD
Atenolol—Somnolence—Furosemide—dilated cardiomyopathy	0.000359	0.00402	CcSEcCtD
Atenolol—Bisoprolol—ADRB1—dilated cardiomyopathy	0.000356	0.0469	CrCbGaD
Atenolol—Esmolol—ADRB2—dilated cardiomyopathy	0.000352	0.0464	CrCbGaD
Atenolol—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000351	0.00393	CcSEcCtD
Atenolol—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00035	0.00392	CcSEcCtD
Atenolol—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000348	0.00391	CcSEcCtD
Atenolol—Fatigue—Furosemide—dilated cardiomyopathy	0.000348	0.0039	CcSEcCtD
Atenolol—Constipation—Furosemide—dilated cardiomyopathy	0.000345	0.00387	CcSEcCtD
Atenolol—Pain—Furosemide—dilated cardiomyopathy	0.000345	0.00387	CcSEcCtD
Atenolol—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000344	0.00386	CcSEcCtD
Atenolol—Acebutolol—ADRB1—dilated cardiomyopathy	0.000337	0.0444	CrCbGaD
Atenolol—Malaise—Lisinopril—dilated cardiomyopathy	0.000335	0.00375	CcSEcCtD
Atenolol—Oxprenolol—ADRB1—dilated cardiomyopathy	0.000334	0.0441	CrCbGaD
Atenolol—Vertigo—Lisinopril—dilated cardiomyopathy	0.000333	0.00374	CcSEcCtD
Atenolol—Syncope—Lisinopril—dilated cardiomyopathy	0.000333	0.00373	CcSEcCtD
Atenolol—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000333	0.00373	CcSEcCtD
Atenolol—Palpitations—Lisinopril—dilated cardiomyopathy	0.000328	0.00368	CcSEcCtD
Atenolol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000326	0.00366	CcSEcCtD
Atenolol—Cough—Lisinopril—dilated cardiomyopathy	0.000324	0.00363	CcSEcCtD
Atenolol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000319	0.00358	CcSEcCtD
Atenolol—Chest pain—Lisinopril—dilated cardiomyopathy	0.000316	0.00354	CcSEcCtD
Atenolol—Anxiety—Lisinopril—dilated cardiomyopathy	0.000315	0.00353	CcSEcCtD
Atenolol—Discomfort—Lisinopril—dilated cardiomyopathy	0.000312	0.0035	CcSEcCtD
Atenolol—Betaxolol—ADRB2—dilated cardiomyopathy	0.00031	0.0408	CrCbGaD
Atenolol—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000309	0.00346	CcSEcCtD
Atenolol—Alprenolol—ADRB1—dilated cardiomyopathy	0.000306	0.0403	CrCbGaD
Atenolol—Confusional state—Lisinopril—dilated cardiomyopathy	0.000305	0.00342	CcSEcCtD
Atenolol—Oedema—Lisinopril—dilated cardiomyopathy	0.000303	0.00339	CcSEcCtD
Atenolol—Bisoprolol—ADRB2—dilated cardiomyopathy	0.000299	0.0394	CrCbGaD
Atenolol—Shock—Lisinopril—dilated cardiomyopathy	0.000298	0.00334	CcSEcCtD
Atenolol—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000296	0.00332	CcSEcCtD
Atenolol—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000295	0.00331	CcSEcCtD
Atenolol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000293	0.00328	CcSEcCtD
Atenolol—Asthenia—Furosemide—dilated cardiomyopathy	0.00029	0.00325	CcSEcCtD
Atenolol—Anorexia—Lisinopril—dilated cardiomyopathy	0.000289	0.00324	CcSEcCtD
Atenolol—Pruritus—Furosemide—dilated cardiomyopathy	0.000285	0.0032	CcSEcCtD
Atenolol—Metoprolol—ADRB1—dilated cardiomyopathy	0.000284	0.0375	CrCbGaD
Atenolol—Acebutolol—ADRB2—dilated cardiomyopathy	0.000283	0.0373	CrCbGaD
Atenolol—Hypotension—Lisinopril—dilated cardiomyopathy	0.000283	0.00317	CcSEcCtD
Atenolol—Oxprenolol—ADRB2—dilated cardiomyopathy	0.000281	0.0371	CrCbGaD
Atenolol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000276	0.0031	CcSEcCtD
Atenolol—Insomnia—Lisinopril—dilated cardiomyopathy	0.000274	0.00307	CcSEcCtD
Atenolol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000272	0.00305	CcSEcCtD
Atenolol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00027	0.00303	CcSEcCtD
Atenolol—Somnolence—Lisinopril—dilated cardiomyopathy	0.000269	0.00302	CcSEcCtD
Atenolol—Dizziness—Furosemide—dilated cardiomyopathy	0.000267	0.00299	CcSEcCtD
Atenolol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000266	0.00299	CcSEcCtD
Atenolol—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000263	0.00295	CcSEcCtD
Atenolol—Pindolol—ADRB1—dilated cardiomyopathy	0.000263	0.0347	CrCbGaD
Atenolol—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000261	0.00293	CcSEcCtD
Atenolol—Fatigue—Lisinopril—dilated cardiomyopathy	0.000261	0.00293	CcSEcCtD
Atenolol—Constipation—Lisinopril—dilated cardiomyopathy	0.000259	0.0029	CcSEcCtD
Atenolol—Pain—Lisinopril—dilated cardiomyopathy	0.000259	0.0029	CcSEcCtD
Atenolol—Alprenolol—ADRB2—dilated cardiomyopathy	0.000257	0.0339	CrCbGaD
Atenolol—Rash—Furosemide—dilated cardiomyopathy	0.000254	0.00285	CcSEcCtD
Atenolol—Dermatitis—Furosemide—dilated cardiomyopathy	0.000254	0.00285	CcSEcCtD
Atenolol—Headache—Furosemide—dilated cardiomyopathy	0.000253	0.00283	CcSEcCtD
Atenolol—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000249	0.0028	CcSEcCtD
Atenolol—Nausea—Furosemide—dilated cardiomyopathy	0.00024	0.00269	CcSEcCtD
Atenolol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000239	0.00268	CcSEcCtD
Atenolol—Metoprolol—ADRB2—dilated cardiomyopathy	0.000239	0.0315	CrCbGaD
Atenolol—Pindolol—ADRB2—dilated cardiomyopathy	0.000221	0.0292	CrCbGaD
Atenolol—Asthenia—Lisinopril—dilated cardiomyopathy	0.000217	0.00244	CcSEcCtD
Atenolol—Pruritus—Lisinopril—dilated cardiomyopathy	0.000214	0.0024	CcSEcCtD
Atenolol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000207	0.00232	CcSEcCtD
Atenolol—Dizziness—Lisinopril—dilated cardiomyopathy	0.0002	0.00224	CcSEcCtD
Atenolol—Rash—Lisinopril—dilated cardiomyopathy	0.000191	0.00214	CcSEcCtD
Atenolol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000191	0.00214	CcSEcCtD
Atenolol—Headache—Lisinopril—dilated cardiomyopathy	0.00019	0.00213	CcSEcCtD
Atenolol—Nausea—Lisinopril—dilated cardiomyopathy	0.00018	0.00202	CcSEcCtD
Atenolol—Propranolol—ADRB1—dilated cardiomyopathy	0.000144	0.0189	CrCbGaD
Atenolol—Propranolol—ADRB2—dilated cardiomyopathy	0.000121	0.0159	CrCbGaD
Atenolol—ADRB2—Adrenoceptors—ADRB1—dilated cardiomyopathy	1.36e-06	0.103	CbGpPWpGaD
Atenolol—ADRB1—Adrenoceptors—ADRB2—dilated cardiomyopathy	1.12e-06	0.0854	CbGpPWpGaD
Atenolol—ADRB2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	4.8e-07	0.0365	CbGpPWpGaD
Atenolol—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	4.55e-07	0.0346	CbGpPWpGaD
Atenolol—ADRB2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	4.04e-07	0.0307	CbGpPWpGaD
Atenolol—ADRB1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	3.98e-07	0.0302	CbGpPWpGaD
Atenolol—ADRB2—Arf6 signaling events—AGTR1—dilated cardiomyopathy	3.91e-07	0.0297	CbGpPWpGaD
Atenolol—ADRB1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	3.34e-07	0.0254	CbGpPWpGaD
Atenolol—ADRB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	3.11e-07	0.0236	CbGpPWpGaD
Atenolol—ADRB2—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	3.09e-07	0.0235	CbGpPWpGaD
Atenolol—ADRB2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	3.04e-07	0.0231	CbGpPWpGaD
Atenolol—ADRB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	3.02e-07	0.023	CbGpPWpGaD
Atenolol—ADRB2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	2.96e-07	0.0225	CbGpPWpGaD
Atenolol—ADRB2—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	2.83e-07	0.0215	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	2.51e-07	0.019	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	2.45e-07	0.0186	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Other—CXCR3—dilated cardiomyopathy	2.2e-07	0.0167	CbGpPWpGaD
Atenolol—ADRB1—Endothelin Pathways—RAF1—dilated cardiomyopathy	2.05e-07	0.0156	CbGpPWpGaD
Atenolol—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	1.67e-07	0.0126	CbGpPWpGaD
Atenolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	1.44e-07	0.0109	CbGpPWpGaD
Atenolol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	1.38e-07	0.0105	CbGpPWpGaD
Atenolol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	1.31e-07	0.00995	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	1.29e-07	0.00979	CbGpPWpGaD
Atenolol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	1.21e-07	0.00921	CbGpPWpGaD
Atenolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	1.19e-07	0.00904	CbGpPWpGaD
Atenolol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	1.19e-07	0.00901	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	1.08e-07	0.00823	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	1.05e-07	0.00799	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	1.03e-07	0.00782	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.78e-08	0.00743	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.57e-08	0.00727	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	9.27e-08	0.00704	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	9.09e-08	0.0069	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	9.02e-08	0.00685	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	9.02e-08	0.00685	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	8.82e-08	0.0067	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	8.82e-08	0.0067	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	8.45e-08	0.00641	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	8.38e-08	0.00637	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	8.2e-08	0.00623	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	8.14e-08	0.00619	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	8.09e-08	0.00615	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	7.94e-08	0.00603	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	7.92e-08	0.00601	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	7.68e-08	0.00583	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.93e-08	0.00526	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.87e-08	0.00521	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.87e-08	0.00521	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.78e-08	0.00515	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.72e-08	0.0051	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.72e-08	0.0051	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.58e-08	0.00499	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.38e-08	0.00485	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.24e-08	0.00474	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	6.05e-08	0.00459	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.28e-08	0.00401	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.26e-08	0.00399	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.16e-08	0.00392	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.12e-08	0.00389	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.12e-08	0.00389	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	5.01e-08	0.0038	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.88e-08	0.0037	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.77e-08	0.00362	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.76e-08	0.00361	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4.17e-08	0.00317	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	4.02e-08	0.00305	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.94e-08	0.00299	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.88e-08	0.00295	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.88e-08	0.00295	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.8e-08	0.00288	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.8e-08	0.00288	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	3.71e-08	0.00282	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	3.63e-08	0.00276	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.61e-08	0.00274	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.53e-08	0.00268	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.52e-08	0.00268	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.52e-08	0.00268	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	3.46e-08	0.00263	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	3.46e-08	0.00263	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.45e-08	0.00262	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.45e-08	0.00262	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.42e-08	0.0026	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.28e-08	0.00249	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	3.25e-08	0.00247	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.2e-08	0.00243	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.1e-08	0.00236	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.98e-08	0.00227	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.94e-08	0.00223	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.92e-08	0.00222	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.83e-08	0.00215	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.71e-08	0.00206	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.65e-08	0.00201	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.61e-08	0.00198	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.57e-08	0.00195	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.34e-08	0.00178	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.29e-08	0.00174	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.2e-08	0.00167	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.15e-08	0.00163	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.1e-08	0.00159	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.08e-08	0.00158	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.08e-08	0.00158	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.05e-08	0.00156	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.04e-08	0.00155	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.04e-08	0.00155	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2e-08	0.00152	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.95e-08	0.00148	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.93e-08	0.00147	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.91e-08	0.00145	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.89e-08	0.00144	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.86e-08	0.00142	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.83e-08	0.00139	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.79e-08	0.00136	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.71e-08	0.0013	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.6e-08	0.00122	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.57e-08	0.00119	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.52e-08	0.00115	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.32e-08	0.001	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.3e-08	0.000991	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.29e-08	0.000983	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.28e-08	0.000969	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.18e-08	0.000895	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.15e-08	0.000876	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.13e-08	0.000855	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1.1e-08	0.000837	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.04e-08	0.000788	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.07e-09	0.000689	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.88e-09	0.000674	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	7.98e-09	0.000606	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.82e-09	0.000594	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CD36—dilated cardiomyopathy	7.78e-09	0.000591	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.65e-09	0.000581	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AGT—dilated cardiomyopathy	7e-09	0.000532	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.36e-09	0.000407	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	5.24e-09	0.000398	CbGpPWpGaD
